INS and diabetes mellitus: Some evidence suggests that TRT might offer cardiovascular benefits by improving body composition, insulin sensitivity, endothelial function, inflammatory status, and lipid profiles in hypogonadal men with type 2 diabetes mellitus [68], [71], [45], [12], potentially resulting in decreased mortality versus untreated hypogonadal men with diabetes [72].